Passage BIO(PASG)
搜索文档
Passage BIO(PASG) - 2021 Q4 - Earnings Call Transcript
2022-03-04 03:54
Passage Bio, Inc. (NASDAQ:PASG) Q4 2021 Earnings Conference Call March 3, 2022 8:30 AM ET Company Participants Stuart Henderson - VP, IR and Strategic Finance Bruce Goldsmith - President and CEO Eliseo Salinas - Chief Research and Development Officer Simona King - CFO Conference Call Participants Tessa Romero - J.P. Morgan Securities Omari Baruti - Goldman Sachs Neena Bitritto-Garg - Citi Yaron Werber - Cowen Debjit Chattopadhyay - Guggenheim Securities Laura Chico - Wedbush Securities Danielle Brill - Raym ...
Passage Bio (PASG) Presents At 2022 WORLD Symposium Data Conference
2022-02-15 02:09
| --- | --- | --- | --- | |---------------------------------------------------------------|-------|-------|----------------------------------------------| | | | | | | | | | PBGM01 Study in Infantile GM1 Gangliosidosis | | | | | | | Interim Safety, Biomarker and Efficacy Results from Low Dose, | | | | | | | | | | Late Infantile Cohort of Ongoing Imagine-1 Clinical Study | | | | | | | | | | | | | | | February 11, 2022 | | | | | | | | | | | | | | | | | | | 2 Welcome & Agenda Bruce Goldsmith, Ph.D. Chief Execut ...
Passage Bio (PASG) Presents At J.P. Morgan 40th Annual Healthcare Conference
2022-02-04 04:15
J.P. Morgan 40th Annual Healthcare Conference Bruce Goldsmith, Ph.D. President and Chief Executive Officer January 10, 2022 2 Forward-Looking Statement This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned initiation of clinical trials and the availability o ...
Passage BIO(PASG) - 2021 Q3 - Earnings Call Transcript
2021-11-07 05:22
Passage Bio, Inc. (NASDAQ:PASG) Q3 2021 Results Conference Call November 4, 2021 8:30 AM ET Company Participants Stuart Henderson - VP, IR and Strategic Finance Bruce Goldsmith - President and CEO Eliseo Salinas - Chief Research and Development Officer Simona King - CFO Conference Call Participants Tessa Romero - JP Morgan Neena Bitritto-Garg - Citi Laura Chico - Wedbush Yun Zhong - BTIG Danielle Brill - Raymond James Brendan Smith - Cowen Operator Good morning, and welcome to the Passage Bio Third Quarter ...
Passage BIO(PASG) - 2021 Q3 - Earnings Call Presentation
2021-11-05 04:32
Fulfilling the Promise of Genetic Medicines for Central Nervous System Disorders Corporate Presentation November 2021 NASDAQ GS: PASG 2 Forward-Looking Statement This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned initiation of clinical trials and the avai ...
Passage Bio (PASG) Investor Presentation - Slideshow
2021-10-08 23:43
Fulfilling the Promise of Genetic Medicines for Central Nervous System Disorders Corporate Presentation October 2021 NASDAQ GS: PASG 2 Forward-Looking Statement This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned initiation of clinical trials and the avail ...
Passage BIO(PASG) - 2021 Q2 - Earnings Call Transcript
2021-08-09 01:39
Passage Bio, Inc. (NASDAQ:PASG) Q2 2021 Earnings Conference Call August 5, 2021 8:30 AM ET Company Participants Stuart Henderson - Vice President of Investor Relations and Strategic Finance Bruce Goldsmith - President and Chief Executive Officer Eliseo Salinas - Chief Research & Development Officer Conference Call Participants Tessa Romero - JPMorgan Neena Bitritto-Garg - Citi Brendan Smith - Cowen and Company Debjit Chattopadhyay - Guggenheim Securities Laura Chico - Wedbush Securities Danielle Brill - Ray ...
Passage BIO(PASG) - 2021 Q1 - Earnings Call Transcript
2021-05-09 19:08
Passage Bio, Inc. (NASDAQ:PASG) Q1 2021 Earnings Conference Call May 5, 2021 8:30 AM ET Company Participants Stuart Henderson - Vice President of Investor Relations and Strategic Finance Bruce Goldsmith - President and Chief Executive Officer Richard Morris - Chief Financial Officer Eliseo Salinas - Chief Research and Development Officer Gary Romano - Chief Medical Officer Jill Quigley - Chief Operating Officer Conference Call Participants Anupam Rama - JPMorgan Chase & Co. Salveen Richter - Goldman Sachs Y ...
Passage BIO(PASG) - 2020 Q4 - Earnings Call Transcript
2021-03-04 04:19
Passage Bio, Inc. (NASDAQ:PASG) Q4 2020 Earnings Conference Call March 3, 2021 8:30 AM ET Company Participants Stuart Henderson - Vice President of Investor Relations and Strategic Finance Bruce Goldsmith - President and Chief Executive Officer Rich Morris - Chief Financial Officer Gary Romano - Chief Medical Officer Jill Quigley - Chief Operating Officer Conference Call Participants Anupam Rama - JP Morgan Salveen Richter - Goldman Sachs Neena Bitritto-Garg - Citi Gbola Amusa - Chardan Laura Chico - Wedbus ...
Passage Bio (PASG) Presents At J.P. Morgan 39th Annual Healthcare Conference - Slideshow
2021-02-12 18:48
Fulfilling the Promise of Gene Therapies for Central Nervous System Disorders 39th Annual J.P. Morgan Healthcare Conference Bruce Goldsmith, PhD | CEO NASDAQ GS: PASG January 11, 2021 Forward-Looking Statement This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our pl ...